Medicover

What Medicover does

Medicover AB (publ) is a Stockholm-listed international healthcare and diagnostic services provider founded in 1995, operating across 18+ countries with 49,000+ employees. The business is organized into two divisions: Diagnostic Services, which runs 1,046 blood collection centers and laboratory facilities serving over 65,000 referring physicians across Central and Eastern Europe, Turkey, and other markets under the Synevo brand; and Healthcare Services, which delivers hospitals, clinics, dental care, fertility treatments, sports medicine, and employer healthcare programs, including 26 hospitals with approximately 6,000 beds in India under Medicover Hospitals.

The company's core technology stack combines high-throughput laboratory diagnostics (clinical chemistry, hematology, microbiology, molecular diagnostics, genetics, and pathology) with proprietary genetic testing capabilities developed through its 87.2%-owned subsidiary NIPD Genetics, including Non-Invasive Prenatal Testing (NIPT) and an MRD assay for cancer diagnostics scheduled for commercialization in H2 2026. Medicover also distributes AI-powered long-term ECG monitoring technology through a partnership with Kardi AI and operates Medicover Integrated Clinical Services (MICS), providing clinical trial operational services to pharmaceutical and biotech clients across Europe, the United States, and Asia-Pacific.

Medicover generates revenue primarily through fee-for-service arrangements with individual patients, recurring employer healthcare subscriptions with corporate customers, and usage-based diagnostic testing billed to referring physicians and clinics. In 2025 the business served 15.8 million people through Diagnostic Services and more than 14.4 million through Healthcare Services, with FY2025 revenue of €2.38 billion and Q4 2025 organic growth of 10.6%. The company has stated a three-year financial target of revenue exceeding €3.25 billion and adjusted organic EBITDA above €600 million by 2028.

Name

Medicover

Legal name

Medicover AB (publ)

Website

https://medicover.com

Company type

Public

Founded year

1995

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

Medicover is a Stockholm-listed international healthcare and diagnostic services provider operating across 18+ countries, serving 30+ million patients annually through Diagnostic Services (lab testing for 65,000+ referring physicians) and Healthcare Services (hospitals, clinics, fertility, dental, and employer health programs), with major presence in Central and Eastern Europe and India.

Ownership category

akta.pro rank

Headquarters

HQ city

Stockholm

HQ country

Sweden

HQ region

Europe

Offices7 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain, Marketing or Sales

Revenue model

1. Healthcare Services: Medicover's Healthcare Services division provides hospital and clinical services including fertility, sports medicine, dental care, and general healthcare. Services are provided to corporate customers (employer healthcare plans) and individual patients. Revenue is generated through fee-for-service arrangements. The division achieved organic growth of 11% and margin expansion to 17% in 2025.
2. Diagnostic Services: Medicover's Diagnostic Services division provides laboratory diagnostic services including routine tests, specialized testing, and genetic diagnostics. Services are provided to over 65,000 referring physicians. The division achieved double-digit growth across all fee-for-service markets with margins improving to 17.3% in 2025.
3. Integrated Clinical Services (MICS): Medicover Integrated Clinical Services (MICS) provides clinical trial operational experience and local networks for global multinational clinical trials across Europe, the United States, and the Asia-Pacific region, partnering with GCCL for specimen analysis capabilities.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels4 records

Core offering

Medicover is a specialised provider of diagnostic and healthcare services operating through two divisions. Diagnostic Services delivers laboratory testing, genetic testing, histopathology, and clinical trial services to referring physicians and patients. Healthcare Services delivers hospital care, outpatient clinics, fertility, dental, sports medicine, and employer healthcare programs to corporate customers and individual patients across Central and Eastern Europe and India.

Differentiator

Problem solved

Functional benefit

Brands

• Medicover Genetics: Genetic testing and diagnostics services including MRD assays for cancer detection
• Medicover Integrated Clinical Services (MICS)
• Synevo
• Medicover Foundation

Products and services

• Diagnostic Services (Synevo and affiliated laboratories) Centralized laboratory diagnostic testing services including routine and specialized tests, histopathology, microbiology, molecular diagnostics, and pathology, delivered to referring physicians, hospitals, and patients across Central and Eastern Europe and India.
• Healthcare Services (Hospitals, Clinics, Employer Healthcare) Vertically integrated healthcare delivery including hospitals, outpatient clinics, fertility treatments, dental care, sports medicine, and employer-sponsored healthcare programs for individual patients and corporate customers across Europe and India.
• Medicover Genetics (MRD Assay and Genetic Testing) Genetic testing services including Non-Invasive Prenatal Testing (NIPT) for unborn children and an MRD assay using ctDNA detection for early indication of disease progression in non-small cell lung cancer, sold to clinicians, hospitals, and patients through the Medicover Genetics brand.
• Medicover Integrated Clinical Services (MICS) Clinical trial operational services for global pharmaceutical and biotech sponsors across Europe, US, and Asia-Pacific, providing local networks, clinical operations, and specimen analysis in partnership with GCCL.
• Medicover Fertility (Invimed, Wunschkinder Berlin, Ovoria) IVF, fertility treatments, and reproductive medicine services delivered through Medicover Fertility and acquired brands across multiple European markets.
• MeinDentist Dental Clinics Dental care services delivered through MeinDentist clinics in Germany, serving both insured and private-pay patients.
• Sports Medicine and Rehabilitation (Rehasport) Sports medicine, physiotherapy, and rehabilitation services for patients recovering from injury or seeking performance and preventive care.
• Histopathology Services Tissue-based diagnostic and pathology services supporting hospitals, oncologists, and referring physicians with cancer diagnosis and disease characterization.
• AI-Powered Long-term ECG Monitoring (Kardi AI) Long-term ECG monitoring service using Kardi AI technology, offered through Medicover's network for atrial fibrillation detection in post-stroke and at-risk patients.

Quantifiable outcome

• Employees covered by Medicover healthcare have 3.5 more healthy and productive work days per year compared to general population
• +4 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability1 record

Feature3 records

Partnerships

One partnership is on record.

• GCCL (Global Clinical Laboratory)coreStrategic or Co-development Partner · 10 February 2026GCCL and Medicover Integrated Clinical Services (MICS) signed a memorandum of understanding to collaborate on multinational clinical trial services across Europe, United States, and Asia-Pacific region. The partnership combines MICS's clinical trial operational experience and local networks with GCCL's specimen analysis capabilities and project management expertise across Asia including Korea.

Scale indicators11 records

Recent moves8 records

Expansion highlights6 records

Direct peers

• Synlab: One of Europe's largest medical diagnostic services providers operating clinical laboratories across multiple countries. Direct competitor to Medicover's Synevo network in CEE and Germany; Medicover itself acquired SYNLAB's Romanian operations and assets in five other CEE countries in 2025, underscoring direct overlap.
• Unilabs: European clinical laboratory and diagnostics provider operating across more than 15 countries with a network of laboratories and collection centers. Direct competitor to Medicover/Synevo in Western and Central Europe, with similar B2B focus on referring physicians and similar clinical service portfolio.

Broad incumbents

• Sonic Healthcare: Global medical diagnostics company providing laboratory and radiology services across Australia, Europe, and North America. Highly comparable to Medicover's Diagnostic Services division given its scale, multi-country laboratory footprint, and referring-physician network, but operates at much larger scale and broader geographic scope.
• Quest Diagnostics: One of the largest clinical laboratory networks in the United States, offering routine, esoteric, and genetic testing services to referring physicians, hospitals, and patients. Highly comparable business model to Medicover's Diagnostic Services division (Synevo), though materially larger and focused on the US market rather than CEE.
• Labcorp (Laboratory Corporation of America): Major US-based clinical laboratory network providing routine and specialty diagnostics to physicians, hospitals, and biopharma. Closely comparable to Medicover's Synevo lab division in service mix (clinical chemistry, molecular/genetic, esoteric testing) and B2B physician channel, though far larger and primarily US-centric.
• Fresenius Medical Care: Global vertically integrated healthcare services company operating hospitals, dialysis clinics, and care delivery networks primarily across Europe. Comparable to Medicover's broader healthcare services portfolio given its pan-European clinical care footprint, though Fresenius is far larger and more focused on dialysis and specialty services.
• IHH Healthcare (Acibadem): One of the world's largest private hospital groups, with significant operations in Turkey (Acibadem), India (Fortis), and Southeast Asia. Comparable to Medicover in operating multi-country private hospital networks focused on premium and corporate healthcare customers, with particular overlap in Turkish and Indian markets.

Regional players

• Apollo Hospitals Enterprise: One of India's largest hospital chains with a broad multi-specialty hospital network across the country. Direct competitor to Medicover Hospitals India, particularly in southern states like Telangana and Andhra Pradesh where Medicover has built its 6,000-bed platform.
• Fortis Healthcare: Leading Indian multi-specialty hospital chain operated under IHH Healthcare. Comparable to Medicover Hospitals India in terms of inpatient services, geographic spread across India, and corporate healthcare delivery model — both compete for tertiary-care patients in major Indian metros.

Emerging players

• Centogene: Europe-based genetic testing and rare disease diagnostics company focused on hereditary disease screening and multi-omic analysis. Comparable to Medicover Genetics (post-NIPD Genetics acquisition) in the European clinical genetics and NIPT space, though materially smaller and more specialized.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/medicover101020
• LinkedInlinkedin.com/company/medicover

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Subsidiaries14 records

Funding overview

Funding rounds3 records

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A7 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Medicover